U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    TNFRSF1A TNF receptor superfamily member 1A [ Homo sapiens (human) ]

    Gene ID: 7132, updated on 1-Jul-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Association of polymorphisms in the TNFA, TNFRSF1A and TNFRSF1B genes with lepromatous leprosy in Western Mexican patients.

    Association of polymorphisms in the TNFA, TNFRSF1A and TNFRSF1B genes with lepromatous leprosy in Western Mexican patients.
    Montoya-Buelna M, Alvarado-Navarro A, Muñoz-Valle JF, Lopez-Roa RI, Guerrero-Velazquez C, Fafutis-Morris M.

    06/25/2024
    Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.

    Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement.
    Liphaus BL, Silva SC, Palmeira P, Silva CA, Goldenstein-Schainberg C, Carneiro-Sampaio M., Free PMC Article

    04/5/2024
    Progesterone modulates TNF receptors expression by Jurkat cells cultured with plasma from pregnant women with preeclampsia.

    Progesterone modulates TNF receptors expression by Jurkat cells cultured with plasma from pregnant women with preeclampsia.
    da Silva PB, Romão-Veiga M, Ribeiro-Vasques VR, Peraçoli JC, Peraçoli MTS, Amaral LM.

    03/27/2024
    Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma.

    Identification of TNFRSF1A as a novel regulator of carfilzomib resistance in multiple myeloma.
    Zhao J, Yang X, Zhang H, Gu X., Free PMC Article

    01/12/2024
    TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.

    TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.
    Gerritsma AM, Sutera D, Cantarini L, Cattalini M, Lachmann HJ, Minden K, Jansson AF, Touitou I, Bustaffa M, Antón J, Insalaco A, Moreno E, Sanchez-Manubens J, Ruperto N, Frenkel J, Gattorno M, for Eurofever/Eurotraps projects and Paediatric Rheumatology International Trials Organisation (PRINTO).

    11/1/2023
    A novel TNFRSF1A mutation associated with TNF-receptor-associated periodic syndrome and its metabolic signature.

    A novel TNFRSF1A mutation associated with TNF-receptor-associated periodic syndrome and its metabolic signature.
    Steiner JD, Annibal A, Laboy R, Braumann M, Göbel H, Laasch V, Müller RU, Späth MR, Antebi A, Kubacki T., Free PMC Article

    10/5/2023
    TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study.

    TNFR-1 and GDF-15 Are Associated With Plasma Neurofilament Light Chain and Progranulin Among Community-Dwelling Older Adults: A Secondary Analysis of the MAPT Study.
    Giudici KV, de Souto Barreto P, Guyonnet S, Morley JE, Nguyen AD, Aggarwal G, Parini A, Li Y, Bateman RJ, Vellas B, MAPT/DSA Group., Free PMC Article

    04/14/2023
    C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis.

    C-Reactive Protein, Interleukin-6, Trimethylamine-N-Oxide, Syndecan-1, Nitric Oxide, and Tumor Necrosis Factor Receptor-1 in Heart Failure with Preserved Versus Reduced Ejection Fraction: a Meta-Analysis.
    Gui XY, Rabkin SW.

    03/7/2023
    Impact of Tumor Necrosis Factor Receptor 1 (TNFR1) Polymorphism on Dry Eye Disease.

    Impact of Tumor Necrosis Factor Receptor 1 (TNFR1) Polymorphism on Dry Eye Disease.
    Acuna K, Choudhary A, Locatelli E, Rodriguez DA, Martin ER, Levitt RC, Galor A., Free PMC Article

    03/1/2023
    The Influence of Severity and Disease Duration on TNF Receptors' Redistribution in Asthma and Rheumatoid Arthritis.

    The Influence of Severity and Disease Duration on TNF Receptors' Redistribution in Asthma and Rheumatoid Arthritis.
    Alshevskaya A, Lopatnikova J, Zhukova J, Chumasova O, Shkaruba N, Sizikov A, Evsegneeva I, Demina D, Nepomniashchikch V, Karaulov A, Sennikov S., Free PMC Article

    01/21/2023
    Dengue virus downregulates TNFR1- and TLR3-stimulated NF-kappaB activation by targeting RIPK1.

    Dengue virus downregulates TNFR1- and TLR3-stimulated NF-κB activation by targeting RIPK1.
    Udawatte DJ, Lang DM, Currier JR, Medin CL, Rothman AL., Free PMC Article

    11/5/2022
    Phenotype and cytokine profile in a TRAPS Syndrome family with TNFRSF1A p.(Thr79Met): Association with sacro-iliitis.

    Phenotype and cytokine profile in a TRAPS Syndrome family with TNFRSF1A p.(Thr79Met): Association with sacro-iliitis.
    Dingulu G, Delwail A, Cuisset L, Lecron JC, Gervais E.

    10/22/2022
    TNF-alpha Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2.

    TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2.
    Pesce B, Ribeiro CH, Larrondo M, Ramos V, Soto L, Catalán D, Aguillón JC., Free PMC Article

    09/3/2022
    Tumor Necrosis Factor-alpha-Induced C-C Motif Chemokine Ligand 20 Expression through TNF Receptor 1-Dependent Activation of EGFR/p38 MAPK and JNK1/2/FoxO1 or the NF-kappaB Pathway in Human Cardiac Fibroblasts.

    Tumor Necrosis Factor-α-Induced C-C Motif Chemokine Ligand 20 Expression through TNF Receptor 1-Dependent Activation of EGFR/p38 MAPK and JNK1/2/FoxO1 or the NF-κB Pathway in Human Cardiac Fibroblasts.
    Yang CM, Yang CC, Hsu WH, Hsiao LD, Tseng HC, Shih YF., Free PMC Article

    09/3/2022
    Reactive oxygen species-dependent upregulation of death receptor, tumor necrosis factor receptor 1, is responsible for theophylline-mediated cytotoxicity in MDA-MB-231 breast cancer cells.

    Reactive oxygen species-dependent upregulation of death receptor, tumor necrosis factor receptor 1, is responsible for theophylline-mediated cytotoxicity in MDA-MB-231 breast cancer cells.
    Tapadar P, Pal A, Ghosal N, Dutta S, Pal R.

    08/27/2022
    ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m(6)A-dependent manner.

    ATXN2-mediated translation of TNFR1 promotes esophageal squamous cell carcinoma via m(6)A-dependent manner.
    Li R, Zeng L, Zhao H, Deng J, Pan L, Zhang S, Wu G, Ye Y, Zhang J, Su J, Zheng Y, Deng S, Bai R, Zhuang L, Li M, Zuo Z, Lin D, Zheng J, Huang X., Free PMC Article

    07/30/2022
    C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration.

    C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration.
    Wang X, Yang G, Wang Q, Zhao Y, Ding K, Ji C, Shi Z, Li H, Li Y, Li S., Free PMC Article

    06/25/2022
    Redistribution of TNF Receptor 1 and 2 Expression on Immune Cells in Patients with Bronchial Asthma.

    Redistribution of TNF Receptor 1 and 2 Expression on Immune Cells in Patients with Bronchial Asthma.
    Alshevskaya A, Zhukova J, Kireev F, Lopatnikova J, Evsegneeva I, Demina D, Nepomniashchikch V, Gladkikh V, Karaulov A, Sennikov S., Free PMC Article

    06/18/2022
    Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After (90)Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.

    Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After (90)Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity.
    Cousins MM, Devasia TP, Maurino CM, Mikell J, Schipper MJ, Kaza RK, Lawrence TS, Cuneo KC, Dewaraja YK., Free PMC Article

    06/18/2022
    miR-558 Reduces the Damage of HBE Cells Exposed to Cigarette Smoke Extract by Targeting TNFRSF1A and Inactivating TAK1/MAPK/NF-kappaB Pathway.

    miR-558 Reduces the Damage of HBE Cells Exposed to Cigarette Smoke Extract by Targeting TNFRSF1A and Inactivating TAK1/MAPK/NF-κB Pathway.
    Jing X, Luan Z, Liu B.

    06/11/2022
    Acute Kidney Injury Associates with Long-Term Increases in Plasma TNFR1, TNFR2, and KIM-1: Findings from the CRIC Study.

    Acute Kidney Injury Associates with Long-Term Increases in Plasma TNFR1, TNFR2, and KIM-1: Findings from the CRIC Study.
    McCoy IE, Hsu JY, Bonventre JV, Parikh CR, Go AS, Liu KD, Ricardo AC, Srivastava A, Cohen DL, He J, Chen J, Rao PS, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators., Free PMC Article

    06/11/2022
    Zika virus-induced TNF-alpha signaling dysregulates expression of neurologic genes associated with psychiatric disorders.

    Zika virus-induced TNF-α signaling dysregulates expression of neurologic genes associated with psychiatric disorders.
    Kung PL, Chou TW, Lindman M, Chang NP, Estevez I, Buckley BD, Atkins C, Daniels BP., Free PMC Article

    05/14/2022
    Role of the Interaction of Tumor Necrosis Factor-alpha and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells.

    Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells.
    Kitaura H, Marahleh A, Ohori F, Noguchi T, Nara Y, Pramusita A, Kinjo R, Ma J, Kanou K, Mizoguchi I., Free PMC Article

    03/19/2022
    Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.

    Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.
    Sen T, Li J, Neuen BL, Neal B, Arnott C, Parikh CR, Coca SG, Perkovic V, Mahaffey KW, Yavin Y, Rosenthal N, Hansen MK, Heerspink HJL., Free PMC Article

    03/19/2022
    XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells.

    XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells.
    Wahida A, Müller M, Hiergeist A, Popper B, Steiger K, Branca C, Tschurtschenthaler M, Engleitner T, Donakonda S, De Coninck J, Öllinger R, Pfautsch MK, Müller N, Silva M, Usluer S, Thiele Orberg E, Böttcher JP, Pfarr N, Anton M, Slotta-Huspenina JB, Nerlich AG, Madl T, Basic M, Bleich A, Berx G, Ruland J, Knolle PA, Rad R, Adolph TE, Vandenabeele P, Kanegane H, Gessner A, Jost PJ, Yabal M.

    03/12/2022
    firstprevious page of 21 nextlast